RECENT NEWS
Concern over kidney cancer drug ruling
Cancer Research UK has said that it is “deeply concerned” over NICE’s decision to reject four kidney cancer drugs including: bevacizumab, sorafenib, sunitinib and temsirolimus. Following a preliminary review, NICE has ruled that although the drugs are clinically effective, they are not good value for money for the NHS.
NPSA warns of infusion and sampling problems
The National Patient Safety Agency (NPSA) has issued a Rapid Response Report to healthcare professionals in the UK to offer guidance for arterial line use following reports of problems with infusions and sampling.
Vitamin D link to pain
Low levels of vitamin D may contribute to chronic pain among women, according to a study published in the Annals of Rheumatic Diseases.
EBME conference announced
The National Biomedical and Clinical Engineering Conference is scheduled this year for the 15 October at the National Motorcycle Museum. This popular conference attracts a large audience drawn mainly from the EBME profession.
Maggots provide key to MRSA antibiotic
Scientists at Swansea University have discovered a new type of antibiotic in maggot secretions that can tackle up to 12 different strains of MRSA, as well as E. coli and C. difficile. The antibiotic, named Seraticin, is derived from the maggot secretions of the common green bottle fly (Lucilia sericata) and scientists hope to develop it into an injection, pill or ointment.
Fatalities prompt new guidance on chemotherapy drug
The National Patient Safety Agency (NPSA) has issued guidance on the prescription and administration of vinca alkaloids, a series of intravenous chemotherapy agents, in response to reports of four fatal and serious incidents in which doses of vinca alkaloids intended for intravenous administration were injected in the spine, causing paralysis and death.
Doctors face performance reviews every five years
In proposals, outlined in the report Medical revalidation – principles and next steps, doctors will be required to renew their professional registration every five years, in order to provide assurance that they are practising to the standard that patients, the public and the profession expect. It will also play a part in putting quality at the heart of NHS care – a key element of the proposals outlined in Lord Darzi’s report High quality care for all.
Prostate cancer breakthrough
Trial results from the Institute of Cancer Research that found a new drug, abiraterone, produced significant falls in PSA levels and some tumour shrinkage in men with advanced prostate cancer.
High blood pressure concern
Patients with high blood pressure are up to 600% more likely to develop dementia according to new research, released by the Alzheimer’s Society. High blood pressure led to a six-fold increase in vascular dementia, the second most common form of dementia in the UK.
Mobile MRI services for Northumbria
InHealth has been working closely with the Northumbria Healthcare NHS Foundation Trust to provide a crucial new mobile MRI service at two of its community hospitals in Northumberland, which will save local patients a 100-mile round trip for specialist examinations.
Leukaemia first at Royal Free
A team at the Royal Free has discovered that patients who achieve remission after chemotherapy develop a type of immune cell called “natural killer cells” which kill any tumour cells left after the chemotherapy treatment.
Plans for ‘survival bonus’ condemned
Plans are being drawn up for surgeons to receive performance-related bonuses, linked to mortality, infection and cost-effectiveness. The proposal is being discussed by Imperial College Healthcare Trust in London which runs five hospitals including Charing Cross, Hammersmith and Queen Charlotte’s.
One in ten adult deaths due to diabetes
The Juvenile Diabetes Research Foundation (JDRF) has called for more action to be taken to increase awareness of type 1 diabetes and its devastating complications, following shocking statistics released by Diabetes UK.
Safety problems highlighted by CMO
Although surgery is generally very safe, a report by the Chief Medical Officer, Sir Liam Donaldson, has highlighted concerns that many inherent risks are not fully appreciated. The latest data published in the report shows that the National Patient Safety Agency received 129,416 reports of potential errors involving surgical procedures during 2007.
Support for surgical safety checklist
With major surgery now occurring at a rate of 234 million procedures per year – one for every 25 people – and studies indicating that a significant percentage result in preventable complications and deaths, WHO has launched a new safety checklist for surgical teams to use in operating theatres, as part of a major drive to make surgery safer around the world.
EBME department’s success recognised
By demonstrating outstanding progress, the electro-biomedical engineering (EBME) department at Bedford Hospital has won the UK’s first Clinical Engineering Team of the Year Award.
Research investigates tests for pre-eclampsia
New research published by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme has assessed methods for predicting and preventing pre-eclampsia, which accounts for complications in up to 8% of all pregnancies.
Making a fist of blood taking
New research shows that the manner in which blood is collected from patients for some blood tests can alter the results. Clenching the fist during blood taking could lead to some patients being directed to their nearest A&E department as a heart emergency. When the test is repeated using correct blood collection technique, it may be found to be a false alarm.
Warning on risks of chest drains
The National Patient Safety Agency (NPSA) has alerted the NHS to the risks associated with inserting chest drains, commonly used on patients with chest trauma, collapsed lungs, or after surgery, to remove air and fluids.
Imaging partnership announced
Medica and Nuffield Health have announced a diagnostics partnership which they claim will create the largest remote radiology reporting network in the UK. Nuffield Health Diagnostics said that the agreement has the potential to deliver substantial benefits to the NHS and independent healthcare sector through reduced cost and increased availability of services across all the major modalities. Under the terms of the agreement, Nuffield Health Diagnostics has acquired Medica for an undisclosed sum.
Latest Issues
IDSc Annual Conference 2024
Hilton Birmingham Metropole Hotel
26th - 27th November 2024
IV Forum 2024
Birmingham Conference & Events Centre (BCEC)
Wednesday 4th December 2024
The AfPP Roadshow - Leeds
TBA, Leeds
7th December 2024
The Fifth Annual Operating Theatres Show 2025
Kia Oval, London
11th March 2025, 9:00am - 4:00pm
Infection Prevention and Control 2025 Conference and Exhibition
The National Conference Centre, Birmingham
29th – 30th April 2025
Decontamination and Sterilisation 2025 Conference and Exhibition
The National Conference Centre, Birmingham
11th April 2025